The role of vasoactive intestinal peptide (VIP) in atropine-related inhibition of the progression of myopia.
Atropine
Form-deprivation myopia
Guinea pig
Vasoactive intestinal polypeptide (VIP)
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
26 Jan 2024
26 Jan 2024
Historique:
received:
07
12
2022
accepted:
16
01
2024
medline:
27
1
2024
pubmed:
27
1
2024
entrez:
26
1
2024
Statut:
epublish
Résumé
This study aimed to investigate the potential involvement of vasoactive intestinal polypeptide (VIP) in myopia development and its contribution to the mechanism of action of the anti-myopia drug, atropine. Thirty-three-week-old guinea pigs were randomly divided into normal control (NC, n = 10), monocularly form-deprived (FDM, n = 10), and FDM treated with 1% atropine (FDM + AT, n = 10) groups. The diopter and axial length were measured at 0, 2, and 4 weeks. Guinea pig eyeballs were removed at week four, fixed, and stained for morphological changes. Immunohistochemistry (IHC) and in situ hybridization (ISH) were performed to evaluate VIP protein and mRNA levels. The FDM group showed an apparent myopic shift compared to the control group. The results of the H&E staining were as follows: the cells of the inner/outer nuclear layers and retinal ganglion cells were disorganized; the choroidal thickness (ChT), blood vessel lumen, and area were decreased; the sclera was thinner, with disordered fibers and increased interfibrillar space. IHC and ISH revealed that VIP's mRNA and protein expressions were significantly up-regulated in the retina of the FDM group. Atropine treatment attenuated FDM-induced myopic shift and fundus changes, considerably reducing VIP's mRNA and protein expressions. The findings of elevated VIP mRNA and protein levels observed in the FDM group indicate the potential involvement of VIP in the pathogenesis and progression of myopia. The ability of atropine to reduce this phenomenon suggests that this may be one of the molecular mechanisms for atropine to control myopia.
Identifiants
pubmed: 38279089
doi: 10.1186/s12886-024-03309-9
pii: 10.1186/s12886-024-03309-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
41Informations de copyright
© 2024. The Author(s).
Références
Bruce A. Re: Holden et al.:: Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050 (Ophthalmology 2016;123:1036-1042). Ophthalmology. 2017;124(3):e24–5. https://doi.org/10.1016/j.ophtha.2016.06.066 . 01616420. https://linkinghub.elsevier.com/retrieve/pii/S0161642016308533 . https://api.elsevier.com/content/article/PII:S0161642016308533?httpAccept=text/plain .
doi: 10.1016/j.ophtha.2016.06.066
pubmed: 28219507
Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990–2010: A systematic analysis. Lancet Glob Health. 2013;1(6):e339–49. https://doi.org/10.1016/S2214-109X(13)70113-X . 2214-109X (Electronic); 2214-109X (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=25104599&query_hl=1 .
doi: 10.1016/S2214-109X(13)70113-X
pubmed: 25104599
Vutipongsatorn K, Yokoi T, Ohno-Matsui K. Current and emerging pharmaceutical interventions for myopia. Br J Ophthalmol. 2019;103(11):1539–48. https://doi.org/10.1136/bjophthalmol-2018-313798 . 1468-2079 (Electronic); 0007-1161 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=31097440&query_hl=1 .
doi: 10.1136/bjophthalmol-2018-313798
pubmed: 31097440
Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012;379(9827):1739–48. https://doi.org/10.1016/S0140-6736(12)60272-4 . 1474-547X (Electronic); 0140-6736 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=22559900&query_hl=1 .
doi: 10.1016/S0140-6736(12)60272-4
pubmed: 22559900
Thomson K, Karouta C, Ashby R. Topical application of dopaminergic compounds can inhibit deprivation myopia in chicks. Exp Eye Res. 2020;200:108233. https://doi.org/10.1016/j.exer.2020.108233 . 1096-0007 (Electronic); 0014-4835 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=32919992&query_hl=1 .
doi: 10.1016/j.exer.2020.108233
pubmed: 32919992
Zhou X, Pardue MT, Iuvone PM, et al. Dopamine signaling and myopia development: What are the key challenges. Prog Retin Eye Res. 2017;61:60–71. https://doi.org/10.1016/j.preteyeres.2017.06.003 . 1873-1635 (Electronic); 1350-9462 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28602573&query_hl=1 .
doi: 10.1016/j.preteyeres.2017.06.003
pubmed: 28602573
pmcid: 5653403
Carr BJ, Stell WK. Nitric oxide (NO) mediates the inhibition of Form-Deprivation myopia by atropine in chicks. Sci Rep. 2016;6(1):9. https://doi.org/10.1038/s41598-016-0002-7 . 2045-2322 (Electronic); 2045-2322 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28442706&query_hl=1 .
doi: 10.1038/s41598-016-0002-7
pubmed: 28442706
pmcid: 5431363
Barathi VA, Chaurasia SS, Poidinger M, et al. Involvement of GABA transporters in atropine-treated myopic retina as revealed by iTRAQ quantitative proteomics. J Proteome Res. 2014;13(11):4647–58. https://doi.org/10.1021/pr500558y . 1535-3907 (Electronic); 1535-3893 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=25211393&query_hl=1 .
doi: 10.1021/pr500558y
pubmed: 25211393
pmcid: 4227558
Ashby R, Kozulin P, Megaw PL, et al. Alterations in ZENK and glucagon RNA transcript expression during increased ocular growth in chickens. Mol Vis. 2010;16:639–6491090-0535. (Electronic); 1090-0535 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20405027&query_hl=1 .
pubmed: 20405027
pmcid: 2855734
Zou L, Liu R, Zhang X, et al. Upregulation of regulator of G-protein signaling 2 in the sclera of a form deprivation myopic animal model. Mol Vis. 2014;20:977–9871090-0535. (Electronic); 1090-0535 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=25018620&query_hl=1 .
pubmed: 25018620
pmcid: 4087119
Troger J, Kieselbach G, Teuchner B, et al. Peptidergic nerves in the eye, their source and potential pathophysiological relevance. Brain Res Rev. 2007;53(1):39–62. https://doi.org/10.1016/j.brainresrev.2006.06.002 . 0165-0173 (Print); 0165-0173 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16872680&query_hl=1 .
doi: 10.1016/j.brainresrev.2006.06.002
pubmed: 16872680
Cakmak AI, Basmak H, Gursoy H, et al. Vasoactive intestinal peptide, a promising agent for myopia? Int J Ophthalmol. 2017;10(2):211–6. https://doi.org/10.18240/ijo.2017.02.05 . 2222-3959 (Print); 2222-3959 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28251078&query_hl=1 .
doi: 10.18240/ijo.2017.02.05
pubmed: 28251078
pmcid: 5313542
Shi Y, Gong B, Chen L, et al. A genome-wide meta-analysis identifies two novel loci associated with high myopia in the Han Chinese population. Hum Mol Genet. 2013;22(11):2325–33. https://doi.org/10.1093/hmg/ddt066 . 1460-2083 (Electronic); 0964-6906 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23406873&query_hl=1 .
doi: 10.1093/hmg/ddt066
pubmed: 23406873
Makman MH, Brown JH, Mishra RK. Cyclic AMP in retina and caudate nucleus: Influence of dopamine and other agents. Adv Cyclic Nucleotide Res. 1975;5:661–6790084-5930. (Print); 0084-5930 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=165691&query_hl=1 .
pubmed: 165691
Watling KJ, Dowling JE. Effects of vasoactive intestinal peptide and other peptides on cyclic AMP accumulation in intact pieces and isolated horizontal cells of the teleost retina. J Neurochem. 1983;41(5):1205–13. https://doi.org/10.1111/j.1471-4159.1983.tb00813.x . 0022-3042 (Print); 0022-3042 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=6194261&query_hl=1 .
doi: 10.1111/j.1471-4159.1983.tb00813.x
pubmed: 6194261
Chaiseha Y, Youngren OM, El HM. Dopamine receptors influence vasoactive intestinal peptide release from turkey hypothalamic explants. Neuroendocrinology. 1997;65(6):423–9. https://doi.org/10.1159/000127205 . 0028-3835 (Print); 0028-3835 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9208404&query_hl=1 .
doi: 10.1159/000127205
pubmed: 9208404
Korkmaz O, Ay H, Ulupinar E, et al. Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats. J Mol Neurosci. 2012;48(3):565–73. https://doi.org/10.1007/s12031-012-9781-x . 1559-1166 (Electronic); 0895-8696 (Linking). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=22544516&query_hl=1 .
doi: 10.1007/s12031-012-9781-x
pubmed: 22544516
Mao JF, Liu SZ. Mechanism of the DL-alpha-aminoadipic acid inhibitory effect on form-deprived myopia in guinea pig. Int J Ophthalmol. 2013;6(1):19–22. https://doi.org/10.3980/j.issn.2222-3959.2013.01.04 . 2222-3959 (Print); 2222-3959 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23447057&query_hl=1 .
doi: 10.3980/j.issn.2222-3959.2013.01.04
pubmed: 23447057
pmcid: 3580243
Mathis U, Schaeffel F. Glucagon-related peptides in the mouse retina and the effects of deprivation of form vision. Graefes Arch Clin Exp Ophthalmol. 2007;245(2):267–75. https://doi.org/10.1007/s00417-006-0282-x . 0721-832X (Print); 0721-832X (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16741711&query_hl=1 .
doi: 10.1007/s00417-006-0282-x
pubmed: 16741711
Brand C, Burkhardt E, Schaeffel F, et al. Regulation of Egr-1, VIP, and Shh mRNA and Egr-1 protein in the mouse retina by light and image quality. Mol Vis. 2005;11:309–3201090-0535. (Electronic); 1090-0535 (Linking); http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15889015&query_hl=1 .
pubmed: 15889015
Tkatchenko AV, Walsh PA, Tkatchenko TV, et al. Form deprivation modulates retinal neurogenesis in primate experimental myopia. Proc Natl Acad Sci U S A. 2006;103(12):4681–6. https://doi.org/10.1073/pnas.0600589103 . 0027-8424 (Print); 0027-8424 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16537371&query_hl=1 .
doi: 10.1073/pnas.0600589103
pubmed: 16537371
pmcid: 1400590
McGlinn AM, Baldwin DA, Tobias JW, et al. Form-deprivation myopia in chick induces limited changes in retinal gene expression. Invest Ophthalmol Vis Sci. 2007;48(8):3430–6. https://doi.org/10.1167/iovs.06-1538 . 0146-0404 (Print); 0146-0404 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17652709&query_hl=1 .
doi: 10.1167/iovs.06-1538
pubmed: 17652709
Zhong W, Lan C, Gu Z, et al. The mechanosensitive piezo1 channel mediates mechanochemical transmission in myopic eyes. Invest Ophthalmol Vis Sci. 2023;64(7):1. https://doi.org/10.1167/iovs.64.7.1 . 1552-5783 (Electronic); 0146-0404 (Print); 0146-0404 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=37261388&query_hl=1 .
doi: 10.1167/iovs.64.7.1
pubmed: 37261388
pmcid: 10241313
Yang Q, Tan QQ, Lan CJ, et al. The changes of KCNQ5 expression and potassium microenvironment in the retina of myopic guinea pigs. Front Physiol. 2021;12:790580. https://doi.org/10.3389/fphys.2021.790580 . 1664-042X (Print); 1664-042X (Electronic); 1664-042X (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35002772&query_hl=1 .
doi: 10.3389/fphys.2021.790580
pubmed: 35002772
pmcid: 8733613
Turnbull PR, Backhouse S, Phillips JR. Visually guided eye growth in the squid. Curr Biol. 2015;25(18):R791–2. https://doi.org/10.1016/j.cub.2015.07.073 . 1879-0445 (Electronic); 0960-9822 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26394098&query_hl=1 .
doi: 10.1016/j.cub.2015.07.073
pubmed: 26394098
Brown DM, Mazade R, Clarkson-Townsend D, et al. Candidate pathways for retina to scleral signaling in refractive eye growth. Exp Eye Res. 2022;219:109071. https://doi.org/10.1016/j.exer.2022.109071 . 1096-0007 (Electronic); 0014-4835 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35447101&query_hl=1 .
doi: 10.1016/j.exer.2022.109071
pubmed: 35447101
pmcid: 9701099
Gupta SK, Chakraborty R, Verkicharla PK. Electroretinogram responses in myopia: A review. Doc Ophthalmol. 2022;145(2):77–95. https://doi.org/10.1007/s10633-021-09857-5 . 1573-2622 (Electronic); 0012-4486 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34787722&query_hl=1 .
doi: 10.1007/s10633-021-09857-5
pubmed: 34787722
Fain G, Sampath AP. Rod and cone interactions in the retina. F1000Res. 2018;7. https://doi.org/10.12688/f1000research.14412.1.2046-1402 (Print); 2046–1402 (Linking) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=29899971&query_hl=1 .
Summers JA, Schaeffel F, Marcos S, et al. Functional integration of eye tissues and refractive eye development: Mechanisms and pathways. Exp Eye Res. 2021;209:108693. https://doi.org/10.1016/j.exer.2021.108693 . 1096-0007 (Electronic); 0014-4835 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34228967&query_hl=1 .
doi: 10.1016/j.exer.2021.108693
pubmed: 34228967
Xiao H, Fan ZY, Tian XD, et al. Comparison of form-deprived myopia and lens-induced myopia in guinea pigs. Int J Ophthalmol. 2014;7(2):245–50. https://doi.org/10.3980/j.issn.2222-3959.2014.02.10 . 2222-3959 (Print); 2227-4898 (Electronic); 2222-3959 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=24790865&query_hl=1 .
doi: 10.3980/j.issn.2222-3959.2014.02.10
pubmed: 24790865
pmcid: 4003077
Akrouh A, Kerschensteiner D. Morphology and function of three VIP-expressing amacrine cell types in the mouse retina. J Neurophysiol. 2015;114(4):2431–8. https://doi.org/10.1152/jn.00526.2015 . 1522-1598 (Electronic); 0022-3077 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26311183&query_hl=1 .
doi: 10.1152/jn.00526.2015
pubmed: 26311183
pmcid: 4620131
Perez DSML, Solomon A, Sheets K, et al. Multiple cell types form the VIP amacrine cell population. J Comp Neurol. 2019;527(1):133–58. https://doi.org/10.1002/cne.24234 . 1096-9861 (Electronic); 0021-9967 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28472856&query_hl=1 .
doi: 10.1002/cne.24234
Vessey KA, Rushforth DA, Stell WK. Glucagon- and secretin-related peptides differentially alter ocular growth and the development of form-deprivation myopia in chicks. Invest Ophthalmol Vis Sci. 2005;46(11):3932–42. https://doi.org/10.1167/iovs.04-1027 . 0146-0404 (Print); 0146-0404 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16249466&query_hl=1 .
doi: 10.1167/iovs.04-1027
pubmed: 16249466
Leung KH, Luo S, Kwarteng R, et al. The myopia susceptibility locus vasoactive intestinal peptide receptor 2 (VIPR2) contains variants with opposite effects. Sci Rep. 2019;9(1):18165. https://doi.org/10.1038/s41598-019-54619-8 . 2045-2322 (Electronic); 2045-2322 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=31796800&query_hl=1 .
doi: 10.1038/s41598-019-54619-8
pubmed: 31796800
pmcid: 6890636
Yiu WC, Yap MK, Fung WY, et al. Genetic susceptibility to refractive error: Association of vasoactive intestinal peptide receptor 2 (VIPR2) with high myopia in Chinese. Plos One. 2013;8(4):e61805. https://doi.org/10.1371/journal.pone.0061805 . 1932-6203 (Electronic); 1932-6203 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23637909&query_hl=1 .
doi: 10.1371/journal.pone.0061805
pubmed: 23637909
pmcid: 3630195
Chakraborty R, Yang V, Park HN, et al. Lack of cone mediated retinal function increases susceptibility to form-deprivation myopia in mice. Exp Eye Res. 2019;180:226–30. https://doi.org/10.1016/j.exer.2018.12.021 . 1096-0007 (Electronic); 0014-4835 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=30605665&query_hl=1 .
doi: 10.1016/j.exer.2018.12.021
pubmed: 30605665
White CM, Ji S, Cai H, et al. Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders. CNS Neurol Disord Drug Targets. 2010;9(5):661–6. https://doi.org/10.2174/187152710793361595 . 1996-3181 (Electronic); 1871-5273 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20632962&query_hl=1 .
doi: 10.2174/187152710793361595
pubmed: 20632962
pmcid: 2967653
Atlasz T, Werling D, Song S, et al. Retinoprotective effects of TAT-Bound vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide. J Mol Neurosci. 2019;68(3):397–407. https://doi.org/10.1007/s12031-018-1229-5 . 1559-1166 (Electronic); 0895-8696 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=30542799&query_hl=1 .
doi: 10.1007/s12031-018-1229-5
pubmed: 30542799
Steingart RA, Solomon B, Brenneman DE, et al. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J Mol Neurosci. 2000;15(3):137–45. https://doi.org/10.1385/JMN:15:3:137 . 0895-8696 (Print); 0895-8696 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11303778&query_hl=1 .
doi: 10.1385/JMN:15:3:137
pubmed: 11303778
Szabadfi K, Danyadi B, Kiss P, et al. Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration. J Mol Neurosci. 2012;48(3):501–7. https://doi.org/10.1007/s12031-012-9774-9 . 1559-1166 (Electronic); 0895-8696 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=22544514&query_hl=1 .
doi: 10.1007/s12031-012-9774-9
pubmed: 22544514
Scuderi S, D’Amico AG, Castorina A, et al. Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic death. J Mol Neurosci. 2014;54(3):395–404. https://doi.org/10.1007/s12031-014-0244-4 . 1559-1166 (Electronic); 0895-8696 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=24488575&query_hl=1 .
doi: 10.1007/s12031-014-0244-4
pubmed: 24488575
Zheng Y, Zeng H, She H, et al. Expression of peptide NAP in rat retinal Muller cells prevents hypoxia-induced retinal injuries and promotes retinal neurons growth. Biomed Pharmacother. 2010;64(6):417–23. https://doi.org/10.1016/j.biopha.2010.01.016 . 1950-6007 (Electronic); 0753-3322 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20359852&query_hl=1 .
doi: 10.1016/j.biopha.2010.01.016
pubmed: 20359852
Nilsson SF, Bill A. Vasoactive intestinal polypeptide (VIP): Effects in the eye and on regional blood flows. Acta Physiol Scand. 1984;121(4):385–92. https://doi.org/10.1111/j.1748-1716.1984.tb07470.x . 0001-6772 (Print); 0001-6772 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=6148840&query_hl=1 .
doi: 10.1111/j.1748-1716.1984.tb07470.x
pubmed: 6148840
Zhou X, Zhang S, Yang F, et al. Decreased choroidal blood perfusion induces myopia in guinea pigs. Invest Ophthalmol Vis Sci. 2021;62(15):30. https://doi.org/10.1167/iovs.62.15.30 . 1552-5783 (Electronic); 0146-0404 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34967855&query_hl=1 .
doi: 10.1167/iovs.62.15.30
pubmed: 34967855
pmcid: 8740532
Zhang S, Zhang G, Zhou X, et al. Changes in choroidal thickness and choroidal blood perfusion in guinea pig myopia. Invest Ophthalmol Vis Sci. 2019;60(8):3074–83. https://doi.org/10.1167/iovs.18-26397 . 1552-5783 (Electronic); 0146-0404 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=31319419&query_hl=1 .
doi: 10.1167/iovs.18-26397
pubmed: 31319419
Lv C, Mo C, Liu H, et al. Dopamine D2-like receptors (DRD2 and DRD4) in chickens: Tissue distribution, functional analysis, and their involvement in dopamine inhibition of pituitary prolactin expression. Gene. 2018;651:33–43. https://doi.org/10.1016/j.gene.2018.01.087 . 1879-0038 (Electronic); 0378-1119 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=29382572&query_hl=1 .
doi: 10.1016/j.gene.2018.01.087
pubmed: 29382572
Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63(1):182–217. https://doi.org/10.1124/pr.110.002642 . 1521-0081 (Electronic); 0031-6997 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=21303898&query_hl=1 .
doi: 10.1124/pr.110.002642
pubmed: 21303898
Al KA, Kannan M, Kang SW, et al. Regulation of prolactin gene expression by vasoactive intestinal peptide and dopamine in the turkey: Role of Ca signalling. J Neuroendocrinol. 2005;17(10):649–55. https://doi.org/10.1111/j.1365-2826.2005.01352.x . 0953-8194 (Print); 0953-8194 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16159377&query_hl=1 .
doi: 10.1111/j.1365-2826.2005.01352.x
Zou YC, Liu LQ, Zhang MX. The expression of vasoactive intestinal polypeptide in visual cortex-17 in normal visual development and formation of anisometropic amblyopia. Semin Ophthalmol. 2014;29(2):59–65. https://doi.org/10.3109/08820538.2012.760620 . 1744-5205 (Electronic); 0882-0538 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23947335&query_hl=1 .
doi: 10.3109/08820538.2012.760620
pubmed: 23947335
Stone RA, Laties AM, Raviola E, et al. Increase in retinal vasoactive intestinal polypeptide after eyelid fusion in primates. Proc Natl Acad Sci U S A. 1988;85(1):257–60. https://doi.org/10.1073/pnas.85.1.257 . 0027-8424 (Print); 0027-8424 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2448769&query_hl=1 .
doi: 10.1073/pnas.85.1.257
pubmed: 2448769
pmcid: 279523
Raviola E, Wiesel TN. Neural control of eye growth and experimental myopia in primates. Ciba Found Symp. 1990;155(22–38):39–44. https://doi.org/10.1002/9780470514023.ch3 . 0300-5208 (Print); 0300-5208 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2088678&query_hl=1 .
doi: 10.1002/9780470514023.ch3
Wiesel TN, Raviola E. Myopia and eye enlargement after neonatal lid fusion in monkeys. Nature. 1977;266(5597):66–8. https://doi.org/10.1038/266066a0 . 0028-0836 (Print); 0028-0836 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=402582&query_hl=1 .
doi: 10.1038/266066a0
pubmed: 402582
Tran H, Tran YH, Tran TD, et al. A review of myopia control with atropine. J Ocul Pharmacol Ther. 2018;34(5):374–9. https://doi.org/10.1089/jop.2017.0144 . 1557-7732 (Electronic); 1080-7683 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=29715053&query_hl=1 .
doi: 10.1089/jop.2017.0144
pubmed: 29715053
Yi S, Huang Y, Yu SZ, et al. Therapeutic effect of atropine 1% in children with low myopia. J Aapos. 2015;19(5):426–9. https://doi.org/10.1016/j.jaapos.2015.04.006 . 1528-3933 (Electronic); 1091-8531 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26228967&query_hl=1 .
doi: 10.1016/j.jaapos.2015.04.006
pubmed: 26228967
Ye L, Xu H, Shi Y, et al. Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study. Ophthalmol Ther. 2022;11(6):2197–210. https://doi.org/10.1007/s40123-022-00572-1 . 2193-8245 (Print); 2193-6528 (Electronic): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=36175821&query_hl=1 .
doi: 10.1007/s40123-022-00572-1
pubmed: 36175821
pmcid: 9521881
Zhu Q, Goto S, Singh S, et al. Daily or Less Frequent Topical 1% Atropine Slows Defocus-Induced Myopia Progression in Contact Lens-Wearing Guinea Pigs. Transl Vis Sci Technol. 2022;11(3):26. https://doi.org/10.1167/tvst.11.3.26 . 2164-2591 (Electronic); 2164-2591 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35323888&query_hl=1 .
doi: 10.1167/tvst.11.3.26
pubmed: 35323888
pmcid: 8963669
Upadhyay A, Beuerman RW. Biological mechanisms of atropine control of myopia. Eye Contact Lens. 2020;46(3):129–35. https://doi.org/10.1097/ICL.0000000000000677 . 1542-233X (Electronic); 1542-2321 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=31899695&query_hl=1 .
doi: 10.1097/ICL.0000000000000677
pubmed: 31899695
pmcid: 7176345
Nickla DL, Zhu X, Wallman J. Effects of muscarinic agents on chick choroids in intact eyes and eyecups: Evidence for a muscarinic mechanism in choroidal thinning. Ophthalmic Physiol Opt. 2013;33(3):245–56. https://doi.org/10.1111/opo.12054 . 1475-1313 (Electronic); 0275-5408 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23662958&query_hl=1 .
doi: 10.1111/opo.12054
pubmed: 23662958
pmcid: 3762223
Czepita D. the possibilities of using the newest experimental results in the progressive myopia treatment. Klin Oczna. 1999;101(2):145–1470023-2157. (Print); 0023-2157 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10418242&query_hl=1 .
pubmed: 10418242
Mathis U, Feldkaemper M, Wang M, et al. Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken. Graefes Arch Clin Exp Ophthalmol. 2020;258(2):319–33. https://doi.org/10.1007/s00417-019-04573-y . 1435-702X (Electronic); 0721-832X (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=31879820&query_hl=1 .
doi: 10.1007/s00417-019-04573-y
pubmed: 31879820
Chassine T, Villain M, Hamel CP, et al. How can we prevent myopia progression? Eur J Ophthalmol. 2015;25(4):280–5. https://doi.org/10.5301/ejo.5000571 . 1724-6016 (Electronic); 1120-6721 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=25655598&query_hl=1 .
doi: 10.5301/ejo.5000571
pubmed: 25655598
Wang Q, Yue W, Jiang Z, et al. Synergistic signaling by light and acetylcholine in mouse iris sphincter muscle. Curr Biol. 2017;27(12):1791–800. https://doi.org/10.1016/j.cub.2017.05.022 . 1879-0445 (Electronic); 0960-9822 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28578927&query_hl=1 .
doi: 10.1016/j.cub.2017.05.022
pubmed: 28578927
pmcid: 8577559
Fahrenkrug J, Galbo H, Holst JJ, et al. Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract. J Physiol. 1978;280:405–22. https://doi.org/10.1113/jphysiol.1978.sp012391 . 0022-3751 (Print); 0022-3751 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=690895&query_hl=1 .
doi: 10.1113/jphysiol.1978.sp012391
pubmed: 690895
pmcid: 1282666
Mathis U, Feldkaemper M, Liu H et al. Studies on the interactions of retinal dopamine with choroidal thickness in the chicken. Graefes Arch Clin Exp Ophthalmol 2022. https://doi.org/10.1007/s00417-022-05837-w . 1435-702X (Electronic); 0721–832X (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=36192457&query_hl=1 .
Jiang Y, Zhang Z, Wu Z, et al. Change and Recovery of Choroid Thickness after Short-term Application of 1% Atropine Gel and its Influencing Factors in 6–7-year-old Children. Curr Eye Res. 2021;46(8):1171–7. https://doi.org/10.1080/02713683.2020.1863431 . 1460-2202 (Electronic); 0271-3683 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=33390025&query_hl=1 .
doi: 10.1080/02713683.2020.1863431
pubmed: 33390025
Wu Y, Feng Y, Yang J, et al. Effects of exogenous retinoic acid on ocular parameters in Guinea pigs with form deprivation myopia. Front Cell Dev Biol. 2023;11:1160897. https://doi.org/10.3389/fcell.2023.1160897 . 2296-634X (Print); 2296-634X (Electronic); 2296-634X (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=37020463&query_hl=1 .
doi: 10.3389/fcell.2023.1160897
pubmed: 37020463
pmcid: 10068790
Kim TY, Lee MW, Baek SK, et al. Comparison of retinal layer thicknesses of highly myopic eyes and normal eyes. Korean J Ophthalmol. 2020;34(6):469–77. https://doi.org/10.3341/kjo.2020.0012 . 2092-9382 (Electronic); 1011-8942 (Print); 1011-8942 (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=33307607&query_hl=1 .
doi: 10.3341/kjo.2020.0012
pubmed: 33307607
pmcid: 7738221
Wu Q, Chen Q, Lin B, et al. Relationships among retinal/choroidal thickness, retinal microvascular network and visual field in high myopia. Acta Ophthalmol. 2020;98(6):e709–14. https://doi.org/10.1111/aos.14372 . 1755-3768 (Electronic); 1755-375X (Linking): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=32030900&query_hl=1 .
doi: 10.1111/aos.14372
pubmed: 32030900